How do I buy United Therapeutics (UTHR) stock?

You can purchase shares of United Therapeutics (NASDAQ:UTHR) through any online brokerage.View our list of the best stock brokerages

Who are United Therapeutics (UTHR) competitors?

Other companies in United Therapeutics’s space includes: Exact Sciences Corp (NASDAQ:EXAS), BeOne Medicines Ltd (NASDAQ:ONC), Neurocrine Biosciences Inc (NASDAQ:NBIX), Ionis Pharmaceuticals Inc (NASDAQ:IONS) and Roivant Sciences Ltd (NASDAQ:ROIV).

What is the forecast, or price target, for United Therapeutics (UTHR) stock?

United Therapeutics has a consensus price target of $447.43.

What is the current price for United Therapeutics (UTHR)?

The stock price for United Therapeutics (NASDAQ: UTHR) is $483.23 last updated January 9, 2026 at 5:16 PM EST.

Does United Therapeutics (UTHR) pay a dividend?

There are no upcoming dividends for United Therapeutics.

When is United Therapeutics (NASDAQ:UTHR) reporting earnings?

United Therapeutics does not have any upcoming earnings scheduled.

Is United Therapeutics (UTHR) going to split?

There is no upcoming split for United Therapeutics.

What sector and industry does United Therapeutics (UTHR) operate in?

United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

United Therapeutics (UTHR) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on...

Comments